Cite

HARVARD Citation

    van Boxtel, W. et al. (2017). Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma. Oral oncology. pp. 198-200. [Online]. 
  
Back to record